Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)

NCT00251823 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Eptifibatide facilitated PCI

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators

[object Object]
[object Object]